1 completed, 1 unknown, 1 withdrawn. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Diabetic Macula Edema: new trials by email Literature Review of Diabetic Macula Edema trials Research Report on Diabetic Macula Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Brolucizumab, Aflibercept - Diabetic Macula Edema | Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2021-02-01 | 2021-03-04 | |
| To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema End-Point-Management grid laser, ranibizumab, Bevacizumab - Diabetic Macula Edema | Phase 4 | Unknown | The University of Hong Kong | 60 | 2015-06-01 | 2016-04-19 |
| Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema Photocoagulation, Ranibizumab - Diabetic Macula Edema | Phase 4 | Completed | Shinshu University | 40 | 2014-04-01 | 2018-09-07 |
Ranibizumab (2) · Bevacizumab (1) · Light Coagulation (1) · aflibercept (1) · brolucizumab (1)
Novartis Pharmaceuticals (1) · Shinshu University (1) · The University of Hong Kong (1)
China (1) · Japan (1)